Change provisions relating to the Insurance Producers Licensing Act and the Pharmacy Benefit Manager Licensure and Regulation Act
LB1062 revises Nebraska insurance law in two main areas: insurance producer licensing and pharmacy benefit manager regulation. On the insurance side, it updates provisions governing reciprocal licensing and retaliatory measures, clarifies when nonresident producer licenses may be issued, and sets out procedures for verifying, suspending, revoking, or terminating those licenses. It also adjusts the grounds for discipline, including misrepresentation, fraud, criminal convictions, failure to maintain good standing in a home state, and failure to comply with child support or state income tax obligations.
The bill also changes the fee structure for insurance producer licenses and related appointments, including caps on initial, renewal, late, reinstatement, and business entity fees. It authorizes the Director of Insurance to impose administrative fines and to enforce disciplinary actions even after a license has lapsed or been surrendered. In addition, LB1062 creates or updates licensure requirements for pharmacy benefit managers, including application and renewal fees, renewal deadlines, suspension for noncompliance, and a duty to report material changes in ownership, control, or other qualifying facts.
LB1062 would amend multiple sections of the Insurance Producers Licensing Act and the Pharmacy Benefit Manager Licensure and Regulation Act, while repealing certain original sections tied to the prior statutory text. Its practical effect is to tighten and modernize Nebraska’s licensing and enforcement framework for insurance producers, especially nonresident and business-entity licensees, and to formalize state oversight of pharmacy benefit managers through licensing, renewal, reporting, and penalty provisions. The bill affects insurers, insurance producers, business entities, nonresident applicants, and pharmacy benefit managers operating in Nebraska.
The available record shows no committee transcript or recorded vote history, so there is no direct evidence of debate, support, or opposition in the materials provided. Based on the bill text alone, the measure appears largely administrative and regulatory in nature, focused on aligning Nebraska’s licensing rules with reciprocity and enforcement standards rather than making a broad policy shift. The absence of recorded controversy suggests the bill may have been treated as a technical or compliance-oriented update.
The most likely points of contention are the bill’s expanded enforcement authority, fee changes, and reciprocity provisions. Insurance producers and business entities could object to higher or more rigid licensing costs, while the retaliatory-measures language may raise concerns about how Nebraska responds to other states’ treatment of Nebraska licensees. Pharmacy benefit managers may also scrutinize the new licensing, renewal, and reporting requirements, particularly the authority to suspend licenses for noncompliance and the obligation to disclose material changes in ownership or control.